The investment seeks the balanced accomplishment of three objectives: long-term growth of capital, conservation of principal and current income... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ModerateAllocation
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IHE | 69.67 | 1.24 | +1.81% |
iShares US Pharmaceuticals ETF | |||
UBOT | 23.44 | 0.13 | +0.56% |
Direxion Dly Rbtc AI Atmtn Bl 2X ETF | |||
QBUF | 28.25 | -0.04 | -0.14% |
Innovator Nasdaq-100 10 Buffr ETF - Qt | |||
BWG | 8.60 | -0.05 | -0.58% |
BrandywineGLOBAL Global Income Opportunities Fund | |||
FXI | 38.34 | -0.75 | -1.92% |
iShares China Large-Cap ETF |
A.I.dvisor indicates that over the last year, GBLEX has been closely correlated with RIRCX. These tickers have moved in lockstep 95% of the time. This A.I.-generated data suggests there is a high statistical probability that if GBLEX jumps, then RIRCX could also see price increases.
Ticker / NAME | Correlation To GBLEX | 1D Price Change % | ||
---|---|---|---|---|
GBLEX | 100% | N/A | ||
RIRCX - GBLEX | 95% Closely correlated | N/A | ||
CIREX - GBLEX | 95% Closely correlated | N/A | ||
CIRAX - GBLEX | 95% Closely correlated | N/A | ||
RIREX - GBLEX | 95% Closely correlated | N/A | ||
CAIFX - GBLEX | 94% Closely correlated | N/A | ||
More |